SCHEMBL14286151

SCHEMBL14286151

O=C(NCC1CCCC1)c1cc(-c2nnnn2-c2c(F)cccc2F)c[nH]1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
ROCK2 O75116 2/20 0.39
ROCK1 Q13464 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HDAC6 Q9UBN7 1/20 0.37
CHRM1 P11229 2/20 0.36
MAPK1 P28482 1/20 0.36
MAPK10 P53779 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CCR3 P51677 6/20 0.36
RIPK1 Q13546 1/20 0.36
USP30 Q70CQ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14600765 0.81 ADORA2A (0.41) ADORA2AADORA1ROCK2ROCK1MEN1
SCHEMBL14286159 0.80 ALDH1A1 (0.41) ADORA2AADORA1MEN1KMT2AHDAC6
SCHEMBL14286139 0.78 ROCK2 (0.40) ADORA2AADORA1ROCK2ROCK1MEN1
SCHEMBL14286176 0.74 HPGD (0.52) MEN1KMT2AMAPK1MAPK10
SCHEMBL14286135 0.72 ROCK2 (0.41) ADORA2AADORA1ROCK2ROCK1MEN1
SCHEMBL14286138 0.71 GSK3B (0.45) ADORA2AADORA1ROCK2ROCK1MEN1
SCHEMBL10067970 0.71 PTGES (0.39) ADORA2AADORA1CHRM1CCNA2CDK2
SCHEMBL14286160 0.70 CHRM1 (0.42) ADORA2AADORA1ROCK2ROCK1MEN1
SCHEMBL14286149 0.69 MAPK1 (0.41) MAPK1MAPK10
SCHEMBL5037079 0.68 KCNN4 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7314885-B2 Pyrrole compounds useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-01-01 US disclosed
US-7314885-B2 Pyrrole compounds useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-01-01 US disclosed